COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India

To treat COVID-19 patients, US Food and Drug Administration gave Eli Lilly an emergency use approval for baricitinib in combination with remdesivir last year

from Top India News- News18.com
Read The Rest:news18..